Global In-Vitro Diagnostics (IVD) Market Key Trends, Size, Growth, Shares And Forecast Research Report 2015

Researchmoz added Most up-to-date research on "Global In-Vitro Diagnostics (IVD) Market Report: 2015 Edition" to its huge collection of research reports.

The diagnostic industry is widely classified into two types: In-vitro diagnostics and In-vivo diagnostics. In-vitro tests are executed in glass test tubes, while In-vivo diagnostics tests are executed inside a patient’s body. IVD products are indeed designed and produced for collecting samples derived from the patient’s body and scrutinizing them outside, which are commonly conducted in hospitals, clinics and labs and in personal settings. Apart from the application of IVDs in medical diagnosis and health screening such as checking blood of signs for infections, or urine for the presence of glucose, they are also used in genetic testing, genomics, veterinary diagnostics, food testing, environmental testing, and research.

As per the “Global IVD market report”, market segments such as blood glucose monitoring and clinical chemistry are relatively mature and stable. However, with growing personalized medical treatment trend, molecular diagnostics market is expected to grow significantly with strict regulatory measures.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=488578

The key factors driving the market growth apart from generic macro-economic factors include accelerating diabetic population, increasing sales of medical technological devices, increasing complexity of diseases, and development of cardiac troponin assays. Some of the noteworthy trends observed in the industry are newly growing vitamin D testing market, genome sequencing market, usage of companion diagnostics in oncology, and increased importance of diagnostics. However, the industry remains exposed to certain challenges such as narrow economic moats in diagnostic market, reimbursement issues in clinical laboratory services, laboratory-developed tests waning IVD profits, and government regulation for IVD tests and stringent in genetic based tests.

The report provides a comprehensive study of global in-vitro diagnostic market covering regional markets and major segments. The competition in the global in-vitro diagnostic market is highly amalgamated with large players like Abbott, Siemens, Roche and Johnson and Johnson. All these companies have been profiled in the present report highlighting their key financials and business strategies for their long term growth.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.

Table of Content

1. Overview1.1 Types of IVD Products-
1.2 Types of IVD Tests-
1.3 Market Segments
1.3.1 Technology Type-
1.3.2 EndUser Segmentation
1.4 Uses of IVDs-
1.5 IVD Value Chain

2. IVD Market Analysis
2.1 Global Market

- Market Value
- Regional Breakdown

2.1.1 IVD Market by Technology Type-
2.1.2 IVD Market by Product Type-
2.1.3 IVD Market by Test Location
2.2 Molecular Diagnostics-
2.2.1 Molecular Diagnostic Market by Test Category
2.3 Immunoassays-
2.4 Regional Markets
2.4.1 Europe

- Market Value
- Market Share by Countries

2.4.2 China

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Rising Global Healthcare Expense-
3.1.2 Increasing Global Ageing Population-
3.1.3 Accelerating Global Diabetic Population-
3.1.4 Increasing Global Gross National Income-
3.1.5 Increasing Sales of Medical Technological Devices-
3.1.6 Increasing Complexity of Diseases-
3.1.7 Development of Cardiac Troponin Assays
3.2 Key Trends
3.2.1 Vitamin D Testing Market – New Growing Segment
3.2.2 Illumina – Dominating the Genome Sequencing Market-
3.2.3 Increased Importance of Diagnostics-
3.2.4 Increased Usage of Companion Diagnostic in Oncology
3.3 Challenges
3.3.1 Diagnostic Market Containing Narrow Economic Moats-
3.3.2 More Diagnostic Regulation in Genetic Based Tests-
3.3.3 LaboratoryDeveloped Tests Waning IVD Profits-
3.3.4 Government Regulation for IVD Tests-
3.3.5 Coverage and Reimbursement of Clinical Laboratory Services

4. Competitive Landscape
4.1 Global Market-
4.2 Competition by Segments
4.2.1 Clinical Chemistry-
4.2.2 Blood Glucose Testing-
4.2.3 Microbiology-
4.2.4 Hematology and Flow Cytometry-
4.2.5 Molecular Diagnostic-
4.2.6 Immunoassay-
4.2.7 Tissue Diagnostic
4.3 China

5. Company Profiles
5.1 Abbott Laboratories
5.1.1 Business Overview-
5.1.2 Financial Overview-
5.1.3 Business Strategies
5.2 Siemens AG
5.2.1 Business Overview-
5.2.2 Financial Overview-
5.2.3 Business Strategies
5.3 Roche Holdings AG
5.3.1 Business Overview-
5.3.2 Financial Overview-
5.3.3 Business Strategies
5.4 Johnson & Johnson
5.4.1 Business Overview-
5.4.2 Financial Overview-
5.4.3 Business Strategies

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=488578

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG

This release was published on openPR.